Economic burden of neural tube defects in Germany

Bowles D, Wasiak R, Kissner M, van Nooten F, Engel S, Linder R, Verheyen F, Greiner W (2014)
Public Health 128(3): 274-281.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Bowles, DavidUniBi; Wasiak, R.; Kissner, M.; van Nooten, F.; Engel, S.; Linder, R.; Verheyen, F.; Greiner, WolfgangUniBi
Abstract / Bemerkung
Objective: Failure of closure of the neural tube often leads to serious malformations, including spina bifida, anencephaly and encephalocoele. Despite improvements in medical and surgical treatment, the burden associated with spina bifida is substantial but country-specific data are lacking outside North America. This study aims to improve understanding of the economic implications and burden associated with the morbidity of children and adults with neural tube defects (NTDs) in Germany. Study design: Retrospective data analysis. Methods: 2006-2009 German health insurance data of persons with NTDs (spina bifida and encephalocoele) were analysed to determine the economic burden of illness associated with NTDs in Germany. Cases were identified using ICD-10 codes; data included outpatient and inpatient care, rehabilitation, remedies and medical aids, pharmacotherapy use, long-term care and information on sick leave. The analysis was stratified by age group to provide a burden estimate specific to a person's age. To obtain an indicator of incremental burden to the Statutory Health Insurance (SHI), results were compared to the standardized healthcare expenditures according to the German Risk Compensation Scheme (RSA). Results: Overall, 4141 persons with an ICD code related to NTDs were identified (out of a population of 7.28 million persons screened). The administrative prevalence ranged from 0.54 to 0.58 per 1000 enrollees. Of those, 3952 (95.4%) were diagnosed with spina bifida. The average annual mean healthcare expenditure of persons with spina bifida was (sic)4532 (95% CI = 4375-4689, SD = 9590, Median = 1000), with inpatient care contributing (sic)1358 (30.0%), outpatient care (sic)644 (14.2%), rehabilitation (sic)29 (0.6%), pharmacotherapy (sic)562 (12.4%), and remedies and medical aids (sic)1939 (42.8%). The incremental cost due to spina bifida was substantially higher than the standardized SHI expenditures for all age groups. The difference was highest for persons <= 10 years old ((sic)10,971 vs (sic)2360 for the age group <= 1, (sic)8599 vs (sic)833 for the age group 2-5 years and (sic)10,601 vs (sic)863 for the age group 6-10 years). The difference was smallest for the age group 41-50 years ((sic)2524 vs (sic)1101) and for 71 years and over ((sic)5278 vs (sic)4389). Conclusion: Expenditures of persons with spina bifida exceeded the standardized SHI expenditures, indicating a considerable economic burden. The economic burden is continuous throughout the person's life, with high monetary impact and exposure to the healthcare system (especially in early years of life). Efforts should be devoted to improve the prevention of NTDs and provide appropriate support for persons with NTDs, parents, and caregivers-especially in early years. (C) 2013 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.
Neural tube defects; Encephalocoele; Spina bifida; Healthcare; utilization; Claims data; Healthcare expenditures
Public Health
Page URI


Bowles D, Wasiak R, Kissner M, et al. Economic burden of neural tube defects in Germany. Public Health. 2014;128(3):274-281.
Bowles, D., Wasiak, R., Kissner, M., van Nooten, F., Engel, S., Linder, R., Verheyen, F., et al. (2014). Economic burden of neural tube defects in Germany. Public Health, 128(3), 274-281. doi:10.1016/j.puhe.2013.12.001
Bowles, D., Wasiak, R., Kissner, M., van Nooten, F., Engel, S., Linder, R., Verheyen, F., and Greiner, W. (2014). Economic burden of neural tube defects in Germany. Public Health 128, 274-281.
Bowles, D., et al., 2014. Economic burden of neural tube defects in Germany. Public Health, 128(3), p 274-281.
D. Bowles, et al., “Economic burden of neural tube defects in Germany”, Public Health, vol. 128, 2014, pp. 274-281.
Bowles, D., Wasiak, R., Kissner, M., van Nooten, F., Engel, S., Linder, R., Verheyen, F., Greiner, W.: Economic burden of neural tube defects in Germany. Public Health. 128, 274-281 (2014).
Bowles, David, Wasiak, R., Kissner, M., van Nooten, F., Engel, S., Linder, R., Verheyen, F., and Greiner, Wolfgang. “Economic burden of neural tube defects in Germany”. Public Health 128.3 (2014): 274-281.

6 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Failures in reproductive health policy: overcoming the consequences and causes of inaction.
Sher J, Frank JW, Doi L, de Caestecker L., J Public Health (Oxf) 41(2), 2019
PMID: 30137572
Ambulatory Care Use among Patients with Spina Bifida: Change in Care from Childhood to Adulthood.
Shepard CL, Doerge EJ, Eickmeyer AB, Kraft KH, Wan J, Stoffel JT., J Urol 199(4), 2018
PMID: 29113842
Estimates of global and regional prevalence of neural tube defects for 2015: a systematic analysis.
Blencowe H, Kancherla V, Moorthie S, Darlison MW, Modell B., Ann N Y Acad Sci 1414(1), 2018
PMID: 29363759
Effectiveness of Stretch Interventions for Children With Neuromuscular Disabilities: Evidence-Based Recommendations.
Craig J, Hilderman C, Wilson G, Misovic R., Pediatr Phys Ther 28(3), 2016
PMID: 27341572
Preventable spina bifida and anencephaly in Europe.
Obeid R, Pietrzik K, Oakley GP, Kancherla V, Holzgreve W, Wieser S., Birth Defects Res A Clin Mol Teratol 103(9), 2015
PMID: 26178749
The unresolved debate on lowering the recommended dietary intake for folate.
Obeid R, Koletzko B, Pietrzik K., Clin Nutr 33(4), 2014
PMID: 24856435

30 References

Daten bereitgestellt von Europe PubMed Central.

Developmental abnormalities of the central nervous system
Verity, 2005
Epidemiology of neural tube defects.
Frey L, Hauser WA., Epilepsia 44 Suppl 3(), 2003
PMID: 12790881
Neural tube defects: prevalence, etiology and prevention.
Kondo A, Kamihira O, Ozawa H., Int. J. Urol. 16(1), 2009
PMID: 19120526
Effects and safety of periconceptional folate supplementation for preventing birth defects
De-Regil, Cochrane Database Syst Rev (10), 2010
Reevaluating the benefits of folic acid fortification in the United States: economic analysis, regulation, and public health.
Grosse SD, Waitzman NJ, Romano PS, Mulinare J., Am J Public Health 95(11), 2005
PMID: 16195513
Cost-effectiveness of a folic acid fortification program in Chile
Llanos, Health Policy 83(2–3), 2007
Spina bifida.
Mitchell LE, Adzick NS, Melchionne J, Pasquariello PS, Sutton LN, Whitehead AS., Lancet 364(9448), 2004
PMID: 15555669

European, 2010
Survival of infants with neural tube defects in the presence of folic acid fortification.
Bol KA, Collins JS, Kirby RS; National Birth Defects Prevention Network., Pediatrics 117(3), 2006
PMID: 16510661
Survival of infants with spina bifida: a population study, 1979-94.
Wong LY, Paulozzi LJ., Paediatr Perinat Epidemiol 15(4), 2001
PMID: 11703686
Rehabilitation and medical management of the adult with spina bifida.
Dicianno BE, Kurowski BG, Yang JM, Chancellor MB, Bejjani GK, Fairman AD, Lewis N, Sotirake J., Am J Phys Med Rehabil 87(12), 2008
PMID: 18923330
Spina bifida outcome: a 25-year prospective.
Bowman RM, McLone DG, Grant JA, Tomita T, Ito JA., Pediatr Neurosurg 34(3), 2001
PMID: 11359098
Health care expenditures of children and adults with spina bifida in a privately insured U.S. population.
Ouyang L, Grosse SD, Armour BS, Waitzman NJ., Birth Defects Res. Part A Clin. Mol. Teratol. 79(7), 2007
PMID: 17335056
Hospital stays, hospital charges, and in-hospital deaths among infants with selected birth defects--United States, 2003.
Centers for Disease Control and Prevention (CDC)., MMWR Morb. Mortal. Wkly. Rep. 56(2), 2007
PMID: 17230142
Labor market productivity costs for caregivers of children with spina bifida: a population-based analysis.
Tilford JM, Grosse SD, Goodman AC, Li K., Med Decis Making 29(1), 2008
PMID: 18725406
Hospitalizations of adults with spina bifida and congenital spinal cord anomalies.
Dicianno BE, Wilson R., Arch Phys Med Rehabil 91(4), 2010
PMID: 20382283
Use of health care among adults with chronic and complex physical disabilities of childhood.
Young NL, Steele C, Fehlings D, Jutai J, Olmsted N, Williams JI., Disabil Rehabil 27(23), 2005
PMID: 16523542

Datenmeldungen für den morbiditätsorientierten Risikostrukturausgleich
Schmidt, 2010
RSA-Jahresausgleich 2007 – Daten und Fakten
Otto, 2010
Economic burden of neural tube defects and impact of prevention with folic acid: a literature review.
Yi Y, Lindemann M, Colligs A, Snowball C., Eur. J. Pediatr. 170(11), 2011
PMID: 21594574
Assistive technology use among adolescents and young adults with spina bifida.
Johnson KL, Dudgeon B, Kuehn C, Walker W., Am J Public Health 97(2), 2006
PMID: 17194874
Prevention of neural tube defects: results of the Medical Research Council Vitamin Study
MRC, Lancet 338(8760), 1991
Folic acid to reduce neonatal mortality from neural tube disorders.
Blencowe H, Cousens S, Modell B, Lawn J., Int J Epidemiol 39 Suppl 1(), 2010
PMID: 20348114
Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force.
Wolff T, Witkop CT, Miller T, Syed SB; U.S. Preventive Services Task Force., Ann. Intern. Med. 150(9), 2009
PMID: 19414843


Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®


PMID: 24559770
PubMed | Europe PMC

Suchen in

Google Scholar